Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients

Srivastava, Raghvendra M and Jie, Hyun-bae and Ferrone, Soldano and Ferris, Robert L (2013) STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients. Journal for ImmunoTherapy of Cancer, 1 (Suppl ). P175 - P175. ISSN 2051-1426

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (212kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Srivastava, Raghvendra Mrms100@pitt.eduRMS100
Jie, Hyun-bae
Ferrone, Soldano
Ferris, Robert L
Date: 2013
Date Type: Publication
Journal or Publication Title: Journal for ImmunoTherapy of Cancer
Volume: 1
Number: Suppl
Page Range: P175 - P175
DOI or Unique Handle: 10.1186/2051-1426-1-s1-p175
Schools and Programs: School of Medicine > Immunology
School of Medicine > Otolaryngology
School of Medicine > Surgery
Refereed: Yes
ISSN: 2051-1426
Date Deposited: 02 Dec 2016 17:40
Last Modified: 16 Oct 2017 23:56
URI: http://d-scholarship.pitt.edu/id/eprint/29650

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item